These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 19101658)
1. Wnt signaling in Alzheimer's disease: up or down, that is the question. Boonen RA; van Tijn P; Zivkovic D Ageing Res Rev; 2009 Apr; 8(2):71-82. PubMed ID: 19101658 [TBL] [Abstract][Full Text] [Related]
2. Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease. Fuentealba RA; Farias G; Scheu J; Bronfman M; Marzolo MP; Inestrosa NC Brain Res Brain Res Rev; 2004 Dec; 47(1-3):275-89. PubMed ID: 15572177 [TBL] [Abstract][Full Text] [Related]
3. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils. De Ferrari GV; Chacón MA; Barría MI; Garrido JL; Godoy JA; Olivares G; Reyes AE; Alvarez A; Bronfman M; Inestrosa NC Mol Psychiatry; 2003 Feb; 8(2):195-208. PubMed ID: 12610652 [TBL] [Abstract][Full Text] [Related]
4. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease. Toledo EM; Inestrosa NC Mol Psychiatry; 2010 Mar; 15(3):272-85, 228. PubMed ID: 19621015 [TBL] [Abstract][Full Text] [Related]
5. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Padmanabhan J; Levy M; Dickson DW; Potter H Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932 [TBL] [Abstract][Full Text] [Related]
6. Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease. Huang HC; Jiang ZF J Alzheimers Dis; 2009; 16(1):15-27. PubMed ID: 19158417 [TBL] [Abstract][Full Text] [Related]
7. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation. Song MS; Rauw G; Baker GB; Kar S Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381 [TBL] [Abstract][Full Text] [Related]
8. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease]. Xu BG; Wu X Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563 [TBL] [Abstract][Full Text] [Related]
10. Calcium/calmodulin-dependent protein kinase type IV is a target gene of the Wnt/beta-catenin signaling pathway. Arrázola MS; Varela-Nallar L; Colombres M; Toledo EM; Cruzat F; Pavez L; Assar R; Aravena A; González M; Montecino M; Maass A; Martínez S; Inestrosa NC J Cell Physiol; 2009 Dec; 221(3):658-67. PubMed ID: 19711354 [TBL] [Abstract][Full Text] [Related]
11. Variations in the neuropathology of familial Alzheimer's disease. Shepherd C; McCann H; Halliday GM Acta Neuropathol; 2009 Jul; 118(1):37-52. PubMed ID: 19306098 [TBL] [Abstract][Full Text] [Related]
12. The role of Wnt signaling in neuroprotection. Cerpa W; Toledo EM; Varela-Nallar L; Inestrosa NC Drug News Perspect; 2009 Dec; 22(10):579-91. PubMed ID: 20140278 [TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease. Wu ZL; Ciallella JR; Flood DG; O'Kane TM; Bozyczko-Coyne D; Savage MJ Neurobiol Aging; 2006 Mar; 27(3):377-86. PubMed ID: 15927307 [TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Ferrer I; Barrachina M; Puig B Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379 [TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease: beta-Amyloid protein and tau. Morishima-Kawashima M; Ihara Y J Neurosci Res; 2002 Nov; 70(3):392-401. PubMed ID: 12391602 [TBL] [Abstract][Full Text] [Related]
16. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer. Tsuchiya K; Nakamura T; Okamoto R; Kanai T; Watanabe M Gastroenterology; 2007 Jan; 132(1):208-20. PubMed ID: 17241872 [TBL] [Abstract][Full Text] [Related]
17. Wnt/β-catenin signal pathway stabilizes APP intracellular domain (AICD) and promotes its transcriptional activity. Zhou F; Gong K; van Laar T; Gong Y; Zhang L Biochem Biophys Res Commun; 2011 Aug; 412(1):68-73. PubMed ID: 21798242 [TBL] [Abstract][Full Text] [Related]
18. Modeling sporadic Alzheimer's disease: the insulin resistant brain state generates multiple long-term morphobiological abnormalities including hyperphosphorylated tau protein and amyloid-beta. Salkovic-Petrisic M; Osmanovic J; Grünblatt E; Riederer P; Hoyer S J Alzheimers Dis; 2009; 18(4):729-50. PubMed ID: 19661616 [TBL] [Abstract][Full Text] [Related]
19. Dysfunctional Wnt/β-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer's disease. Liu L; Wan W; Xia S; Kalionis B; Li Y Neurochem Int; 2014 Sep; 75():19-25. PubMed ID: 24859746 [TBL] [Abstract][Full Text] [Related]
20. The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells. Esposito G; De Filippis D; Carnuccio R; Izzo AA; Iuvone T J Mol Med (Berl); 2006 Mar; 84(3):253-8. PubMed ID: 16389547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]